Topchoice Medical Co., Inc. (SHA: 600763)
China
· Delayed Price · Currency is CNY 54.46
-1.40 (-2.51%)
Nov 13, 2024, 3:00 PM CST
Topchoice Medical Co. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 487.01 | 500.47 | 548.27 | 702.81 | 492.63 | 466.12 | Upgrade
|
| Depreciation & Amortization | 188.82 | 188.82 | 173.31 | 153.8 | 62.65 | 60.79 | Upgrade
|
| Other Amortization | 55.79 | 55.79 | 46.1 | 35 | 30.22 | 29.71 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.05 | 0.02 | - | 0.31 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.42 | 0.42 | 0.51 | 0.21 | 0.34 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -60.19 | -60.19 | -38.3 | -56.13 | -38.86 | -32.91 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.75 | 1.75 | 1.67 | 1.29 | 0.47 | 0.39 | Upgrade
|
| Other Operating Activities | 166.38 | 131.85 | 117.71 | 109.25 | 71.83 | 70.61 | Upgrade
|
| Change in Accounts Receivable | -37.49 | -37.49 | -45.07 | -46.88 | -4.27 | -27.26 | Upgrade
|
| Change in Inventory | -1.9 | -1.9 | -2.55 | -2.68 | -1.27 | 7.86 | Upgrade
|
| Change in Accounts Payable | 69.82 | 69.82 | -122.12 | 36.97 | 90.84 | 55.22 | Upgrade
|
| Change in Other Net Operating Assets | -1.64 | -1.64 | -1.64 | -1.64 | -1.64 | 22.52 | Upgrade
|
| Operating Cash Flow | 861.02 | 839.95 | 670.05 | 939.41 | 708.5 | 658.96 | Upgrade
|
| Operating Cash Flow Growth | 9.82% | 25.36% | -28.67% | 32.59% | 7.52% | 40.38% | Upgrade
|
| Capital Expenditures | -511.37 | -505.45 | -421.53 | -367.32 | -170.49 | -127.59 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.1 | 0.01 | 0.62 | 0.02 | 4.69 | 0.03 | Upgrade
|
| Cash Acquisitions | -17.73 | - | - | - | -65.37 | -11.3 | Upgrade
|
| Divestitures | -0.03 | -0.03 | - | 131.95 | - | - | Upgrade
|
| Investment in Securities | -127.49 | -504.25 | -60.45 | -234.42 | 13.71 | -46.24 | Upgrade
|
| Other Investing Activities | 12.27 | -14.47 | -15.99 | -14 | -77.03 | -239.75 | Upgrade
|
| Investing Cash Flow | -504.24 | -884.18 | -497.35 | -483.77 | -294.49 | -424.85 | Upgrade
|
| Long-Term Debt Issued | - | 280 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -193.57 | -251.18 | -241.76 | -95 | -75 | Upgrade
|
| Net Debt Issued (Repaid) | -186.87 | 86.43 | -251.18 | -241.76 | -95 | -75 | Upgrade
|
| Repurchase of Common Stock | -1 | -1 | -99.99 | - | - | - | Upgrade
|
| Common Dividends Paid | -150.96 | -11.24 | -6.69 | -12.87 | -21.08 | -24.17 | Upgrade
|
| Other Financing Activities | -101.23 | -65.43 | -28.33 | -31.3 | -120.03 | 5.36 | Upgrade
|
| Financing Cash Flow | -440.06 | 8.76 | -386.19 | -285.93 | -236.11 | -93.81 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | -0 | - | Upgrade
|
| Net Cash Flow | -83.28 | -35.47 | -213.5 | 169.71 | 177.9 | 140.3 | Upgrade
|
| Free Cash Flow | 349.65 | 334.5 | 248.52 | 572.09 | 538.01 | 531.37 | Upgrade
|
| Free Cash Flow Growth | -16.92% | 34.60% | -56.56% | 6.33% | 1.25% | 132.18% | Upgrade
|
| Free Cash Flow Margin | 12.08% | 11.75% | 9.14% | 20.57% | 25.77% | 27.52% | Upgrade
|
| Free Cash Flow Per Share | 0.78 | 0.75 | 0.55 | 1.27 | 1.20 | 1.18 | Upgrade
|
| Cash Income Tax Paid | 148.35 | 142.48 | 227.01 | 105.67 | 105.05 | 117.49 | Upgrade
|
| Levered Free Cash Flow | 341.03 | 334.03 | -199.6 | 365.3 | 484.05 | 363.4 | Upgrade
|
| Unlevered Free Cash Flow | 378.26 | 368.41 | -168.32 | 383.37 | 495.77 | 378.07 | Upgrade
|
| Change in Net Working Capital | -217.26 | -195.27 | 425.55 | 18.96 | -166.93 | -21.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.